Can the psychedelic ibogaine really get to the root of trauma? In Ibogaine Uncovered, author and journalist Amanda Siebert explores the impact of this powerful medicine including what prompts people to seek it out and how their lives are often transformed through the teachings they receive.
Guests take an honest look at their healing journey, unpacking their lived experiences with substance use disorder, complex trauma, depression, anxiety, eating disorders, and grief.
Expert guests also provide listeners with wisdom for their own healing journey. Join Siebert for powerful conversations that highlight the value of preparation, integration, and community in the world of ibogaine healing.
Kerry Rhodes is a former NFL safety who played in the league for 9 years, first for the New York Jets and then for the Arizona Cardinals, until 2013. Today he is a musician, writer, director, producer, and actor, who hasn’t exactly shied away from talking about his own personal use of psychedelics and how they have changed his life for the better.
Kerry’s experiences with psychedelic medicine
the role psychedelics could have for folks in professional sports leagues
the role of the supporter: what does it look like to support a family member, a friend, a loved one through the ibogaine experience?
How to best support someone who is about to undergo an ibogaine treatment
The importance of preparation, integration, and community advice for those in a supporter’s role
Why it’s important: Supporting a loved one through a traumatic period in their lives can be incredibly challenging, because it requires a level of surrender on the part of the supporter, too – a sense of trust in the process, and a willingness to let go of control. Kerry’s experience shows us how vital support from a loved one can be in taking the initial step to seek treatment, and how that support can allow a person to learn to trust the process, too.
https://beondibogaine.com/wp-content/uploads/2023/01/Beond-Podcast-Graphics-Master-22.png5391029Alexishttps://beondibogaine.com/wp-content/uploads/2023/09/logo-ibogaine-white.svgAlexis2023-01-24 14:23:112024-03-12 21:06:45Kerry Rhodes: The Supporter’s Role
Vianey Ariadna Perez, or Nurse V. as everyone at Beond calls her, is a registered nurse and the head of nursing at Beond.
Nurse V. has overseen more than 500 ibogaine experiences, and a few months ago, she also had her own experience with the powerful medicine. Born in Mexico and raised in Atlanta, Georgia, she studied at a private nursing university and worked in Cancun’s General Hospital in several different departments before she began working with ibogaine in 2018.
There are some obvious things required of Beond’s nursing staff, and some less obvious things. In this episode, Nurse V. discusses some of the finer points of being a nurse in this kind of setting, and shares about her experience of witnessing transformational changes in the people she cares for.
Nurse V. opens up about her own experience with ibogaine in the spring of 2022, and she discusses a topic on the minds of several people in the psychedelic space: is it necessary for people who work with a psychedelic medicine like ibogaine to have their own experience with the medicine?
She also offers up advice to folks with nursing experience who might be considering working in this growing space.
Why it’s important
Nurse V presents a different perspective on ibogaine treatment: not one from the patient’s chair or the science lab but from directly opposite a patient, within the treatment room, and as the leader of a nursing team overseeing several patients who are at different points in their ibogaine treatment plan. Learning about Nurse V’s experiences with ibogaine, both personal and professional, provides a level of insight into treatment that could be new for listeners.
Through the harm reduction model, clients are offered a holistic approach to healing rooted in empathy, one that humanizes them and often leads to improved quality of life.
Dr. Tatarsky is internationally recognized for his work in the treatment of problematic substance use and other risky behaviors. For the last 35 years he’s worked as a counselor, psychologist, program director, trainer, advocate and author, with a focus on harm reduction psychotherapy.
When it comes to therapy for people suffering from substance use disorder, the focus is generally not on harm reduction but on complete abstinence. That’s where this discussion kicks off – talking about the standard practices in the psychotherapy field for addiction.
The belief that people cannot benefit from psychotherapy until they are sober or they’ve stopped using is very common in the field.Dr. Tatarsky’s approach has been the opposite. He speaks to how the harm reduction approach in psychotherapy disproves the idea that one must be abstinent before they can benefit from therapy, and not only that, how traditional models of drug and alcohol treatment can often create further harm for people suffering from addiction. He has a name for this: treatment trauma.
He also discusses the origins of harm reduction psychotherapy, his early involvement in the field, and how it has affected substance use disorder treatment on a broader level.
Amanda asks Dr. Tatarsky some questions critics of harm reduction might have: if the goal of harm reduction therapy is not abstinence, what is it? What are the challenges of a harm reduction approach?
Dr. Tatarsky shares about his work in New York City, the recent implementation of harm reduction measures in the state of New York, and finally, if a harm reduction approach and ibogaine treatment can be complimentary.
Why it’s important
Dr. Tatarsky brings up valid points that challenge standard psychotherapy models for substance use disorder, which are not only ineffective but dehumanizing. Through the harm reduction model, clients are offered a holistic approach to healing rooted in empathy, one that humanizes them and often leads to improved quality of life. Looking at drug treatment more broadly and ibogaine more specifically through his lens might challenge some of the preconceived notions you have about substance use disorder and drug treatment, in a good way.
https://beondibogaine.com/wp-content/uploads/2023/01/Beond-Podcast-Graphics-Master-24.png5391029Robertohttps://beondibogaine.com/wp-content/uploads/2023/09/logo-ibogaine-white.svgRoberto2022-12-14 21:41:002024-03-12 21:07:04Dr. Andrew Tatarsky: Why Drug Abstinence Only Doesn’t Work
Dr. Thomas Kingsley Brown, an anthropologist, chemist and a MAPS researcher who studies the potential for ibogaine-assisted therapy to treat drug addiction, among other things. He is the research program coordinator at the University of California San Diego McNair program, and an advisor to Beond.
What’s covered
How ibogaine stacks up against standard treatment models for addiction
Dr. Brown’s research on the long-term effects of ibogaine treatment: does it last?
The recent history of ibogaine
Who is Howard Lotsof?
How and why ibogaine was scheduled in the United States
Psychedelic drug policy
What Dr. Brown’s research shows about the importance of integration and support after treatment
Can a psychedelic experience feel like a religious conversion?
Why it’s important
If you’re interested in learning more about both the long-term effects of ibogaine, and ibogaine’s history, this episode is for you. Dr. Kingsley Brown also does an excellent job of explaining why ibogaine is where it’s at right now as far as policy and research. His explanations of his own work on ibogaine’s long-term effects speak to the potential that it has in treating addiction effectively.
https://beondibogaine.com/wp-content/uploads/2023/01/Beond-Podcast-Graphics-Master-26.png5391029Robertohttps://beondibogaine.com/wp-content/uploads/2023/09/logo-ibogaine-white.svgRoberto2022-11-29 21:44:002024-03-12 21:08:01Dr. Thomas Kingsley Brown: Ibogaine: Past and Present
Talia Eisenberg, co-founder of Beond, a serial entrepreneur involved in psychedelic healthcare who is most passionate about democratizing access to safe, scientifically backed treatment for addiction and trauma
What’s covered
Talia’s discovery of ibogaine
Her experience at an ibogaine treatment center 13 years ago
The evolution of the ibogaine treatment community
Moving beyond opiate dependency and healing the underlying cause
The importance of meeting people where they are at
What happens during ibogaine treatment
What happens after treatment
Modalities that are complimentary to the post-treatment integration process
Beond’s scholarship program and new Reset programs
Why it’s important
Talia’s story is a wonderful example of the potential ibogaine has to completely turn someone’s life around – and not just that, but how that can 180 can inspire changes that go far beyond one person’s individual journey.
